AMENDED AND RESTATED CREDIT AGREEMENT,Credit Agreement • June 29th, 1998 • Leiner Health Products Inc • Pharmaceutical preparations • New York
EXHIBIT 12.2 ------------------------------------------------------------------ -------------- ---------------------------------------------------------------- ---------------- LEINER HEALTH PRODUCTS INC. COMPUTATION OF EBITDA TO INTEREST EXPENSE...Financial Statement • June 29th, 1998 • Leiner Health Products Inc • Pharmaceutical preparations
1994 1995 1996 1997(1) 1998 ------------- ------------- ------------- ------------- ------------ Net income (loss) $ 3,417 $ 3,813 $ 1,166 $ 7,638 ($17,417) Extraordinary item - - - 2,756 1,109 Income taxes 3,573 3,524 4,686 8,028 1,196 Fixed charges...Computation of Ratio of Earnings to Fixed Charges • June 29th, 1998 • Leiner Health Products Inc • Pharmaceutical preparations
EXHIBIT 21 -------------------------------------------------------------------- ------------ ------------------------------------------------------------------ --------------List of Subsidiaries • June 29th, 1998 • Leiner Health Products Inc • Pharmaceutical preparations
AFFIRMATION AND CONSENT May 15, 1998Affirmation and Consent • June 29th, 1998 • Leiner Health Products Inc • Pharmaceutical preparations
This Affirmation and Consent is delivered to you pursuant to Section 7.1.5 of the Amended and Restated Credit Agreement, dated as of May 15, 1998 (as further amended, supplemented, amended and restated or otherwise modified from time to time, the "CREDIT AGREEMENT"), among Leiner Health Products Inc., a Delaware corporation (the "U.S. BORROWER"), Vita Health Products Inc., a Manitoba corporation (the "CANADIAN BORROWER", and together with the U.S. Borrower, the "BORROWERS"), the various financial institutions as are or may become parties thereto which extend a Commitment under the U.S. Facility (collectively, the "U.S. LENDERS"), the various financial institutions as are or may become parties hereto which extend a Commitment under the Canadian Facility (collectively, the "CANADIAN LENDERS", and together with the U.S. Lenders, the "LENDERS"), The Bank of Nova Scotia ("SCOTIABANK"), as agent for the U.S. Lenders under the U.S. Facility (in such capacity, the "U.S. AGENT"), Scotiabank, cu
